When considering these IgG glycans over the course of HCC progression, it can be seen that some glycans changed at all three investigated time points, including GP2, 4, 5, 8, and 13, while others only changed at later stages in the induction process (Figure 2 and Table 1). The gene discussed is GP2; the disease is hepatocellular carcinoma.